ENOVA ANNOUNCES NEW $400 MILLION SHARE REPURCHASE PROGRAM
CHICAGO, Nov. 12, 2025 /PRNewswire/ — Enova International (NYSE: ENVA), a leading financial services company powered by machine learning and world-class analytics, today... Read more.
Markem-Imaje Launches Enhanced 9712 Bi-Jet Inkjet Printer Model with New Printhead Configuration for High-Speed Applications
DOWNERS GROVE, Ill., Nov. 12, 2025 /PRNewswire/ — Markem-Imaje, part of Dover (NYSE: DOV) and a global provider of end-to-end supply chain solutions and industrial... Read more.
KORE Reports Third Quarter 2025 Results
Growth in Adjusted EBITDA, Connections and Free Cash Flow and an improvement in Net Loss ATLANTA, Nov. 12, 2025 /PRNewswire/ — KORE Group Holdings, Inc. (NYSE:... Read more.
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Transaction streamlines Edgewell’s portfolio and allows the personal care brand to focus on areas of competitive leadership SHELTON, Conn., Nov. 12, 2025 /PRNewswire/... Read more.
CISCO REPORTS FIRST QUARTER EARNINGS
SAN JOSE, Calif., Nov. 12, 2025 /PRNewswire/ — News Summary: Strong top and bottom-line growth, exceeding our guidance and delivering continued operating... Read more.
Tyra Biosciences Announces Participation at Upcoming Investor Events
CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation... Read more.
Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage... Read more.
Resideo To Participate at Upcoming Investor Events
SCOTTSDALE, Ariz., Nov. 12, 2025 /PRNewswire/ — Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven... Read more.
DAWSON GEOPHYSICAL REPORTS THIRD QUARTER 2025 RESULTS
MIDLAND, Texas, Nov. 12, 2025 /PRNewswire/ — Dawson Geophysical Company (NASDAQ: DWSN) (the “Company”) today reported unaudited financial results... Read more.
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001... Read more.